Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-18 Sale |
2020-08-20 6:23 pm |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
8,054 | $158.17 | $1,273,892 | 190,414 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-17 9:40 pm |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
450 | $157.79 | $71,006 | 155,202 (Direct) |
View |
| 2020-08-10 Sale |
2020-08-13 06:04 am |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $156.74 | $4,463,263 | 776,595 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 7:14 pm |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
20,000 | $165.72 | $3,314,418 | 143,181 (Direct) |
View |
| 2020-07-17 Sale |
2020-07-21 7:48 pm |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
8,000 | $179.42 | $1,435,363 | 230,537 (Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 6:07 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $175.08 | $4,984,808 | 970,208 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-07 6:34 pm |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
712 | $167.49 | $119,253 | 55,307 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 7:19 pm |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
11,573 | $167.58 | $1,939,352 | 163,181 (Direct) |
View |
| 2020-06-19 Sale |
2020-06-22 7:46 pm |
SEATTLE GENETICS INC | SGEN | LIU JEAN I GC/EVP, Leg Affairs |
9,877 | $165 | $1,629,705 | 63,597 (Direct) |
View |
| 2020-06-17 Sale |
2020-06-19 5:54 pm |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
2,162 | $158.89 | $343,523 | 109,608 (Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 7:24 pm |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
5,822 | $157.15 | $914,927 | 111,770 (Direct) |
View |
| 2020-06-08 Sale |
2020-06-10 6:57 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $148.77 | $4,235,807 | 1,182,275 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 6:03 pm |
SEATTLE GENETICS INC | SGEN | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
1,750,000 | $160 | $280,000,000 | 43,656,815 (Indirect Direct) |
View |
| 2020-05-12 Sale |
2020-05-14 6:54 pm |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $166 | $1,152,372 | 52,575 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-12 7:51 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $161.01 | $4,584,311 | 1,179,395 (Direct) |
View |
| 2020-05-08 Sale |
2020-05-08 7:54 pm |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $163.02 | $1,131,667 | 59,517 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-08 7:42 pm |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
11,912 | $164.5 | $1,959,526 | 139,181 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-08 5:47 pm |
SEATTLE GENETICS INC | SGEN | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
1,058,316 | $161.85 | $171,290,420 | 45,254,621 (Indirect Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 7:59 pm |
SEATTLE GENETICS INC | SGEN | WELCH DANIEL G Director |
35,000 | $165.9 | $5,806,560 | 55,263 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 7:59 pm |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
50,000 | $165.65 | $8,282,403 | 718,339 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 7:59 pm |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
5,056 | $166.18 | $840,226 | 52,575 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 7:58 pm |
SEATTLE GENETICS INC | SGEN | AKKARAJU SRINIVAS Director |
8,500 | $167.26 | $1,421,710 | 49,168 (Direct) |
View |
| 2020-05-04 Sale |
2020-05-06 6:32 pm |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
41,034 | $157.43 | $6,460,152 | 173,888 (Direct) |
View |
| 2020-05-04 Sale |
2020-05-06 6:19 pm |
SEATTLE GENETICS INC | SGEN | LIPPMAN MARC E Director |
1,000 | $152.03 | $152,030 | 130,313 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-17 Option Award |
2020-08-18 7:53 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | LOVE TED W Director |
6,259 | $0 | 6,259 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:40 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
45,901 | $0 | 155,202 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:34 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
97,365 | $0 | 815,704 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:32 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
27,123 | $0 | 82,430 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:31 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
30,045 | $0 | 173,226 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:29 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
22,951 | $0 | 214,823 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 9:27 pm |
N/A 2030-08-17 |
SEATTLE GENETICS INC | SGEN | LIU JEAN I GC/EVP, Legal Affairs |
25,036 | $0 | 88,633 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $0 | 776,595 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-13 06:04 am |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,475 | $12 | 776,595 (Direct) |
View |
| 2020-07-17 Exercise |
2020-07-21 7:48 pm |
N/A 2021-08-24 |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
8,000 | $0 | 230,537 (Direct) |
View |
| 2020-07-17 Exercise |
2020-07-21 7:48 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | HIMES VAUGHN B Chief Technical Officer |
8,000 | $15.46 | 230,537 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 6:07 pm |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $0 | 970,208 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 6:07 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,072 | $12 | 970,208 (Direct) |
View |
| 2020-06-08 Exercise |
2020-06-10 6:57 pm |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $0 | 1,182,275 (Direct) |
View |
| 2020-06-08 Exercise |
2020-06-10 6:57 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $12 | 1,182,275 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:11 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | WELCH DANIEL G Director |
4,506 | $0 | 59,769 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:11 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | Simonian Nancy A Director |
4,506 | $0 | 29,269 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:11 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | Seth Alpna Director |
4,506 | $0 | 13,219 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:10 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | Orwin John A Director |
4,506 | $0 | 29,269 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:10 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | LIPPMAN MARC E Director |
4,506 | $0 | 134,819 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:10 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | GRYSKA DAVID W Director |
4,506 | $0 | 52,519 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 7:10 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | AKKARAJU SRINIVAS Director |
4,506 | $0 | 44,674 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 6:47 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
3,444 | $0 | 56,019 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 6:03 pm |
2021-05-15 2030-05-15 |
SEATTLE GENETICS INC | SGEN | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
4,506 | $0 | 43,656,815 (Indirect) |
View |
| 2020-05-12 Exercise |
2020-05-14 6:54 pm |
N/A 2021-08-24 |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $0 | 52,575 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-14 6:54 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $15.46 | 52,575 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 7:51 pm |
N/A 2020-08-27 |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $0 | 1,179,395 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 7:51 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIEGALL CLAY B President and CEO |
28,472 | $12 | 1,179,395 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-08 7:54 pm |
N/A 2021-08-24 |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $0 | 59,517 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-08 7:54 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | ROMP CHARLES R EVP, Commercial |
6,942 | $15.46 | 59,517 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 7:42 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
11,912 | $65.11 | 139,181 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 7:42 pm |
N/A 2028-06-15 |
SEATTLE GENETICS INC | SGEN | DANSEY ROGER D Chief Medical Officer |
11,912 | $0 | 139,181 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 7:58 pm |
N/A 2022-05-17 |
SEATTLE GENETICS INC | SGEN | AKKARAJU SRINIVAS Director |
8,500 | $0 | 49,168 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 7:58 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | AKKARAJU SRINIVAS Director |
8,500 | $20.06 | 49,168 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
2,436 | $41.04 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
2,268 | $44.09 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
3,831 | $26.1 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
1,103 | $45.3 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
2,554 | $39.15 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A 2022-08-20 |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
53,226 | $0 | 173,888 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
14,167 | $12 | 173,888 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-06 6:32 pm |
N/A N/A |
SEATTLE GENETICS INC | SGEN | SIMPSON TODD E Chief Financial Officer |
26,867 | $15.46 | 173,888 (Direct) |
View |